Successful Use of Single Doses of Granulocyte-Colony Stimulating Factor (G-CSF) in the Treatment of Late-Onset Agranulocytosis Associated With Clozapine in a Patient With Treatment-Resistant Schizophrenia: A Case Report

J Clin Psychopharmacol. 2016 Apr;36(2):173-4. doi: 10.1097/JCP.0000000000000467.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Agranulocytosis / chemically induced*
  • Agranulocytosis / diagnosis
  • Agranulocytosis / drug therapy*
  • Antipsychotic Agents / adverse effects*
  • Clozapine / adverse effects*
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Male
  • Schizophrenia, Paranoid / diagnosis
  • Schizophrenia, Paranoid / drug therapy*
  • Treatment Outcome

Substances

  • Antipsychotic Agents
  • Granulocyte Colony-Stimulating Factor
  • Clozapine